Den europeiske union -
norsk -
EMA (European Medicines Agency)
vectormune fp ilt + ae
ceva-phylaxia co. ltd. - live recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus (rfp-lt) and avian encephalomyelitis virus, strain calnek 1143 (ae) - immunologicals for aves, live viral vaccines, domestic fowl - kylling - for active immunisation of chickens of 8 to 13 weeks of age in order to reduce the skin lesions due to fowlpox, to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis and to prevent egg production losses due to avian encephalomyelitis.
Norge -
norsk -
Statens legemiddelverk
avipro ae -
lohmann animal health gmbh - aviær encefalomyelittvirus, stamme calnek 1143, levende - suspensjon til bruk i drikkevann
Den europeiske union -
norsk -
EMA (European Medicines Agency)
ervebo
merck sharp & dohme b.v. - rekombinant vesicular stomatitis virus (belastning indiana) med en sletting av konvolutten glykoprotein, erstattet med zaire ebolavirus (belastning kikwit 1995) overflate glykoprotein - hemoragisk feber, ebola - vaksiner - ervebo is indicated for active immunization of individuals 1 year of age or older to protect against ebola virus disease (evd) caused by zaire ebola virus. bruk av ervebo skal være i samsvar med offisielle anbefalinger.
Den europeiske union -
norsk -
EMA (European Medicines Agency)
duoplavin
sanofi winthrop industrie - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - antithrombotic agents - duoplavin er indisert for sekundær forebygging av atherotrombotiske hendelser hos voksne pasienter som allerede tar både klopidogrel og acetylsalisylsyre (asa). duoplavin is a fixed-dose combination medicinal product for continuation of therapy in:non st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary intervention (pci);st segment elevation acute myocardial infarction (stemi) in patients undergoing a stent placement) or medically treated patients eligible for thrombolytic/fibrinolytic therapy. for ytterligere informasjon, vennligst referer til seksjon 5.
Den europeiske union -
norsk -
EMA (European Medicines Agency)
fexeric
akebia europe limited - ferrisitratkoordinasjonskompleks - hyperphosphatemia; renal dialysis - legemidler til behandling av hyperkalemi og hyperfosfatemi - fexeric er indisert for kontroll av hyperfosfatemi hos voksne pasienter med kronisk nyresykdom (ckd).
Norge -
norsk -
Adama
cleave
adama - florasulam 2,5 g/l (0,25 vikt-%) + fluroksypyr-1-metylheptylester 144 g/l (14.2 vikt-%) - ugrasmiddel